MétaCan
Menu
Back to cohort
Record W2159721362 · doi:10.1186/1745-6215-12-s1-a52

Protecting intellectual property associated with health technology trials – another barrier to multi-centre trials?

2011· article· en· W2159721362 on OpenAlexaffabout
Sue Ross, Laura A. Magee, Stephen Wood

Bibliographic record

VenueTrials · 2011
Typearticle
Languageen
FieldMedicine
TopicBiomedical Ethics and Regulation
Canadian institutionsUniversity of British ColumbiaUniversity of Calgary
Fundersnot available
KeywordsMedicineProtocol (science)Intellectual propertyClinical trialPregnancyOpenness to experiencePlaceboInstitutional review boardRandomized controlled trialAlternative medicineFamily medicinePsychiatryLawSurgeryPsychologyPathology

Abstract

fetched live from OpenAlex

To examine the approaches to protection of intellectual property in multi-centre trials currently being conducted in Canada. Two ongoing international multicentre perinatal trials, both funded by the Canadian Institutes of Health Research, were selected for study on the basis of their contrasting approaches to protecting intellectual property. These approaches were examined in detail to understand their motivation, and to estimate the impact of these approaches on centre recruitment. CHIPS (Control of Hypertension in Pregnancy Study, ISRCTN71416914) – is recruiting 1028 pregnant women in 14 countries. Women with hypertension are randomised to tight or less tight control of hypertension. Primary outcome: composite of pregnancy loss/neonatal intensive care. Intellectual property is safeguarded by publishing the protocol online [ 1 ]. Positive consequences: possible/actual sites have easy access to full study design; potential for open discussion between collaborators; study investigators will be held to high standards of reporting. Negative consequences: details are available with potential for plagiarism. FACT (Folic Acid Clinical Trial, ISRCTN23781770) – is recruiting 3656 pregnant women in 4 countries. Pregnant women are randomised to receive either 4 mg folic acid or placebo daily. Primary outcome: development of pre-eclampsia. Intellectual property is safeguarded by requiring local investigators/institutions to sign non-disclosure agreements (NDAs) before the full protocol is provided. Positive consequences: details of the study not available unless legal agreement is signed. Negative consequences: may restrict academic openness; provide additional barriers to site recruitment; investigators may present selected results. The two trials illustrate contrasting approaches to protecting intellectual property associated with study design. This issue is becoming more important for academic institutions whose reputations and wealth are influenced by ownership and management of the intellectual property generated by faculty members. Some institutions prefer to manage risk using legal measures. In the case of trials, institutions protect their intellectual property by introducing NDAs into the sub-site agreement process. NDAs between the lead institution and sub-sites may represent a legally responsible approach. Unfortunately there are potential disadvantages: adding an extra legal step into sub-site recruitment will make this process more difficult; this step may reduce academic openness and collegiality; and restricting the availability of the protocol could allow investigators to present selected results. The use of non-disclosure agreements is an increasing trend in Canada. This trend will impact on the work of clinical trialists, perhaps making site recruitment even more difficult.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.049
metaresearch head score (Gemma)0.145
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMetaresearch, Insufficient payload (model declined to judge)
Consensus categoriesMetaresearch
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Other design · Consensus signal: none
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.803
Threshold uncertainty score0.999

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0490.145
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0030.000
Bibliometrics0.0000.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.432
GPT teacher head0.430
Teacher spread0.001 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; both teacher heads agree on what is shown here.

Study designOther design
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations1
Published2011
Admission routes2
Has abstractyes

Explore more

Same venueTrialsSame topicBiomedical Ethics and RegulationFrench-language works237,207